FRNM and ABT Related Headlines

Go Back

Jul 27, 2026 08:00AM FDA approves Freenome's blood-based colorectal cancer screening test
Jul 27, 2026 08:00AM FDA Approves Freenome’s SimpleScreen™ CRC Blood-Based Screening Test; Abbott to Commercialize in the U.S.

FRNM and ABT Related Press Releases

Go Back

Jul 27, 2026 08:00AM FDA Approves Freenome’s SimpleScreen™ CRC Blood-Based Screening Test; Abbott to Commercialize in the U.S.

FRNM and ABT Related SEC Filings

Go Back